Dosidal · Switzerland

Imipenem-Cilastatin-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:60262 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 60262
atc: J01DH51
Source authoritySwissmedic
Read date2026-11-15T01:25:13Z
authorisation statusfirst_authorisation: 2010-06-24
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J01DH51
authorisation_number: 60262
form: PULPI
holder: Mepha Pharma AG
holder_partner_nr: 1006155
it_number: 08.01.93
name: Imipenem-Cilastatin-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
tU_JyG4a9zpsEgAvz0U_8abY-hHBHMlCR8NjsoUdkOPZG5elnaXxN8tfdFHrhpaSy6rMAS_uWU-iYOwNCBcoaQ
The signed record is on this page as issued. Keyring and how to check it: https://dosidal-registry.ai/.well-known/jwks.json
The signed record (DOSE-10060, JSON)
{"as_of":null,"authority":{"id":"60262","name":"Swissmedic","register":"OGD Praeparate"},"fields":{"authorisation_status":{"asserted_by":"node","clock":{"class":"short","expires_at":"2026-11-22T01:25:13Z"},"effective_from":"2010-06-24","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"first_authorisation":"2010-06-24","term":"zugelassen","valid_until":"9999-12-31"}},"identity":{"asserted_by":"node","clock":{"class":"long","expires_at":"2027-02-13T01:25:13Z"},"effective_from":"2010-06-24","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"atc":"J01DH51","authorisation_number":"60262","form":"PULPI","holder":"Mepha Pharma AG","holder_partner_nr":"1006155","it_number":"08.01.93","name":"Imipenem-Cilastatin-Mepha i.v., Pulver für ein Konzentrat zur Herstellung einer Infusionslösung"}}},"instance":"CH-DOSE-10060","instance_version":"0.1","market":"CH","node":{"door":"https://mcp.dosidal.ai","id":"ch.dose-10060.org"},"notice":"Artificial intelligence makes mistakes. Read the regulator.","produced_at":"2026-11-15T01:25:15Z","record_id":"ch:authorisation:60262","schema_version":"1.0","signature":{"alg":"ES256","canon":"JCS","kid":"dosidal-record-1.9dbf5d53","sig":"tU_JyG4a9zpsEgAvz0U_8abY-hHBHMlCR8NjsoUdkOPZG5elnaXxN8tfdFHrhpaSy6rMAS_uWU-iYOwNCBcoaQ"},"standard":"DOSE-10060","standard_version":"1.0","subject":{"anchor":null,"id":"ch:authorisation:60262","identifiers":[{"system":"swissmedic-authorisation","value":"60262"},{"system":"atc","value":"J01DH51"}],"level":"authorisation","relations":[{"id":"ch:presentation:60262-002","rel":"authorisation_of"}]},"supersedes":null,"version":1}

Dosidal